{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:55:46Z","timestamp":1783490146714,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AstraZeneca AG"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13687-5","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:43:03Z","timestamp":1763984583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hospitalizations and inpatient resource consumption of patients suffering from chronic disease \u2013 Past trend and forecast for Switzerland"],"prefix":"10.1186","volume":"25","author":[{"given":"Daria","family":"Bukanova-Berend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Campbell-James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"13687_CR1","unstructured":"Bundesamt f\u00fcr Gesundheit BAG Abteilung. Pr\u00e4vention nicht\u00fcbertragbarer Krankheiten. Zahlen und Fakten zu nicht\u00fcbertragbaren Krankheiten. 2017."},{"key":"13687_CR2","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10198-018-0963-5","volume":"19","author":"S Wieser","year":"2018","unstructured":"Wieser S, Riguzzi M, Pletscher M, Huber CA, Telser H, Schwenkglenks M. How much does the treatment of each major disease cost? A decomposition of Swiss National health accounts. Eur J Health Econ. 2018;19:1149\u201361. https:\/\/doi.org\/10.1007\/s10198-018-0963-5.","journal-title":"Eur J Health Econ"},{"key":"13687_CR3","unstructured":"Federal Statistical Office. Demografische Bilanz nach Alter und Kanton."},{"key":"13687_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/eurpub\/cks053","volume":"23","author":"A Rosano","year":"2013","unstructured":"Rosano A, Loha CA, Falvo R, van der Zee J, Ricciardi W, Guasticchi G, et al. The relationship between avoidable hospitalization and accessibility to primary care: a systematic review. Eur J Public Health. 2013;23:356\u201360. https:\/\/doi.org\/10.1093\/eurpub\/cks053.","journal-title":"Eur J Public Health"},{"key":"13687_CR5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/fampra\/cmu053","volume":"31","author":"T van Loenen","year":"2014","unstructured":"van Loenen T, van den Berg MJ, Westert GP, Faber MJ. Organizational aspects of primary care related to avoidable hospitalization: a systematic review. Fam Pract. 2014;31:502\u201316. https:\/\/doi.org\/10.1093\/fampra\/cmu053.","journal-title":"Fam Pract"},{"key":"13687_CR6","unstructured":"The Swiss Monitoring. System of Addiction and Noncommunicable diseases."},{"key":"13687_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3390\/healthcare11091229","volume":"11","author":"A Gouveia","year":"2023","unstructured":"Gouveia A, Mauron C, Marques-Vidal P. Potentially avoidable hospitalizations by asthma and COPD in Switzerland from 1998 to 2018: A Cross-Sectional study. Healthcare. 2023;11:1229. https:\/\/doi.org\/10.3390\/healthcare11091229.","journal-title":"Healthcare"},{"key":"13687_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae175.347","author":"K Maung","year":"2024","unstructured":"Maung K, Mauron CHARL\u00c8, Gouveia ALEX, Marques-Vidal PEDRO. Potentially avoidable hospitalizations for heart failure in Switzerland. Eur J Prev Cardiol. 2024. https:\/\/doi.org\/10.1093\/eurjpc\/zwae175.347. 31 Supplement_1.","journal-title":"Eur J Prev Cardiol"},{"key":"13687_CR9","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41440-024-01853-x","volume":"47","author":"P Marques-Vidal","year":"2024","unstructured":"Marques-Vidal P, Maung KK, Gouveia A. Twenty-year trends of potentially avoidable hospitalizations for hypertension in Switzerland. Hypertens Res. 2024;47:2847\u201354. https:\/\/doi.org\/10.1038\/s41440-024-01853-x.","journal-title":"Hypertens Res"},{"key":"13687_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e40466","author":"KK Maung","year":"2024","unstructured":"Maung KK, Mauron C, Gouveia A, Marques-Vidal P. Trends in potentially avoidable hospitalizations for diabetes in Switzerland, 1998 to 2018: Data from multiple cross-sectional studies. Heliyon. 2024;10:e40466. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40466"},{"key":"13687_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","volume":"396","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, et al. Estimating lifetime benefits of comprehensive disease-modifying Pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet. 2020;396:121\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)30748-0.","journal-title":"Lancet"},{"key":"13687_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","volume":"400","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, et al. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022;400:757\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(22)01429-5.","journal-title":"Lancet"},{"key":"13687_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.15326\/jcopdf.2.3.2014.0151","volume":"2","author":"DM Mannino","year":"2015","unstructured":"Mannino DM, Yu T-C, Zhou H, Higuchi K. Effects of GOLD-Adherent prescribing on COPD symptom Burden, Exacerbations, and health care utilization in a Real-World setting. Chronic Obstr Pulm Dis. 2015;2:223\u201335. https:\/\/doi.org\/10.15326\/jcopdf.2.3.2014.0151.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"13687_CR14","doi-asserted-by":"publisher","unstructured":"Thygesen LC, Christiansen T, Garcia-Armesto S, Angulo-Pueyo E, Mart\u00ednez-Lizaga N, Bernal-Delgado E. Potentially avoidable hospitalizations in five European countries in 2009 and time trends from 2002 to 2009 based on administrative data. Eur J Public Health. 2015;25 suppl_1:35\u201343. https:\/\/doi.org\/10.1093\/eurpub\/cku227","DOI":"10.1093\/eurpub\/cku227"},{"key":"13687_CR15","doi-asserted-by":"publisher","first-page":"104948","DOI":"10.1016\/j.healthpol.2023.104948","volume":"139","author":"J Spycher","year":"2024","unstructured":"Spycher J, Morisod K, Moschetti K, Le Pogam M-A, Peytremann-Bridevaux I, Bodenmann P, et al. Potentially avoidable hospitalizations and socioeconomic status in switzerland: A small area-level analysis. Health Policy (New York). 2024;139:104948. https:\/\/doi.org\/10.1016\/j.healthpol.2023.104948.","journal-title":"Health Policy (New York)"},{"key":"13687_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/1472-6963-14-289","volume":"14","author":"C Berlin","year":"2014","unstructured":"Berlin C, Busato A, Rosemann T, Djalali S, Maessen M. Avoidable hospitalizations in switzerland: a small area analysis on regional variation, density of physicians, hospital supply and rurality. BMC Health Serv Res. 2014;14:289. https:\/\/doi.org\/10.1186\/1472-6963-14-289.","journal-title":"BMC Health Serv Res"},{"key":"13687_CR17","unstructured":"Organisation for Economic Cooperation and Development. Healthcare Quality and Outcomes (HCQO) indicators 2022-23 Definitions."},{"key":"13687_CR18","unstructured":"World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems (ICD). https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases. Accessed 1 Nov 2024."},{"key":"13687_CR19","unstructured":"Bundesamt f\u00fcr Statistik. Schweizerische Operationsklassifikation (CHOP). https:\/\/www.bfs.admin.ch\/asset\/de\/23085962. Accessed 1 Nov 2024."},{"key":"13687_CR20","unstructured":"Swiss DRG. SwissDRG AG. https:\/\/www.swissdrg.org\/de. Accessed 1 Nov 2024."},{"key":"13687_CR21","unstructured":"Bl\u00fcmel Miriam S, Anne A, Katharina. Maresso Anna, Reinhard Busse. Germany: health system review 2020. 2020."},{"key":"13687_CR22","unstructured":"Federal Statistical office. Cantonal projections. https:\/\/www.bfs.admin.ch\/bfs\/en\/home\/statistics\/population\/population-projections\/cantonal-projections.html"},{"key":"13687_CR23","volume-title":"Offre et recours aux Soins m\u00e9dicaux ambulatoires En Suisse","author":"HRMBCMNBA Jaccard Ruedin","year":"2007","unstructured":"Jaccard Ruedin HRMBCMNBA. Offre et recours aux Soins m\u00e9dicaux ambulatoires En Suisse. Switzerland: Neuchatel; 2007."},{"key":"13687_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12913-020-5023-z","volume":"20","author":"H Ravaghi","year":"2020","unstructured":"Ravaghi H, Alidoost S, Mannion R, B\u00e9lorgeot VD. Models and methods for determining the optimal number of beds in hospitals and regions: a systematic scoping review. BMC Health Serv Res. 2020;20:186. https:\/\/doi.org\/10.1186\/s12913-020-5023-z.","journal-title":"BMC Health Serv Res"},{"key":"13687_CR25","unstructured":"Ministerium f\u00fcr Arbeit G und S des LN-W. Krankenhausplan Nordrhein-Westfalen. 2022. Die Strukturen m\u00fcssen f\u00fcr die Menschen da sein, nicht die Menschen f\u00fcr die Strukturen! 2022."},{"key":"13687_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-3-662-60487-8_18","volume-title":"Krankenhaus-Report 2020","author":"J Vogel","year":"2020","unstructured":"Vogel J, Letzgus P, Geissler A. Paradigmenwechsel in der Krankenhausplanung \u2013 hin Zu Leistungs-, Bedarfs- und Qualit\u00e4tsorientierung f\u00fcr einen h\u00f6heren patientennutzen. Krankenhaus-Report 2020. Berlin, Heidelberg: Springer Berlin Heidelberg; 2020. pp. 327\u201358. https:\/\/doi.org\/10.1007\/978-3-662-60487-8_18."},{"key":"13687_CR27","unstructured":"Infektionradar. https:\/\/infektionsradar.gesund.bund.de\/en\/overall\/intensivecare. Accessed 1 Dec 2024."},{"key":"13687_CR28","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/eurheartj\/ehx026","volume":"38","author":"W Ouwerkerk","year":"2017","unstructured":"Ouwerkerk W, Voors AA, Anker SD, Cleland JG, Dickstein K, Filippatos G, et al. Determinants and clinical outcome of Uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study. Eur Heart J. 2017;38:1883\u201390. https:\/\/doi.org\/10.1093\/eurheartj\/ehx026.","journal-title":"Eur Heart J"},{"key":"13687_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamacardio.2024.2969","volume":"9","author":"VB Polsinelli","year":"2024","unstructured":"Polsinelli VB, Sun J-L, Greene SJ, Chiswell K, Grunwald GK, Allen LA, et al. Hospital heart failure medical therapy score and associated clinical outcomes and costs. JAMA Cardiol. 2024;9:1029. https:\/\/doi.org\/10.1001\/jamacardio.2024.2969.","journal-title":"JAMA Cardiol"},{"key":"13687_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2024.3023","author":"AB Tang","year":"2024","unstructured":"Tang AB, Ziaeian B, Butler J, Yancy CW, Fonarow GC. Global impact of optimal implementation of Guideline-Directed medical therapy in heart failure. JAMA Cardiol. 2024. https:\/\/doi.org\/10.1001\/jamacardio.2024.3023.","journal-title":"JAMA Cardiol"},{"key":"13687_CR31","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O, Cohen-Solal A, Diaz R, Filippatos G, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400:1938\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1.","journal-title":"Lancet"},{"key":"13687_CR32","doi-asserted-by":"publisher","unstructured":"Dixit NM, Parikh NU, Ziaeian B, Fonarow GC. Economic modeling analysis of an intensive GDMT optimization program in hospitalized heart failure patients. Circ Heart Fail. 2023;16. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.123.011218.","DOI":"10.1161\/CIRCHEARTFAILURE.123.011218"},{"key":"13687_CR33","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.3390\/jcm12206636","volume":"12","author":"V Mangold","year":"2023","unstructured":"Mangold V, Boesing M, Berset C, Bridevaux P-O, Geiser T, Joos Zellweger L, et al. Adherence to the GOLD guidelines in primary care: data from the Swiss COPD cohort. J Clin Med. 2023;12:6636. https:\/\/doi.org\/10.3390\/jcm12206636.","journal-title":"J Clin Med"},{"key":"13687_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3444","author":"R Christodorescu","year":"2024","unstructured":"Christodorescu R, Geavlete O, Ferrini M, K\u00fcmler T, Toutoutzas K, Bayes-Genis A, et al. Translating the 2021\u2009<\u2009scp\u2009>\u2009ESC\u2009heart failure guideline recommendations in daily practice: results from a heart failure survey. A scientific statement of the <\u2009scp\u2009>\u2009ESC\u2009Council for cardiology practice and the heart failure association of the <\u2009scp\u2009>\u2009ESC. Eur J Heart Fail. 2024. https:\/\/doi.org\/10.1002\/ejhf.3444.","journal-title":"Eur J Heart Fail"},{"key":"13687_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, et al. Medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol. 2018;72:351\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.070.","journal-title":"J Am Coll Cardiol"},{"key":"13687_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/eurjpc\/zwac204","volume":"30","author":"RFE Pedretti","year":"2023","unstructured":"Pedretti RFE, Hansen D, Ambrosetti M, Back M, Berger T, Ferreira MC, et al. How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European association of preventive cardiology. Eur J Prev Cardiol. 2023;30:149\u201366. https:\/\/doi.org\/10.1093\/eurjpc\/zwac204.","journal-title":"Eur J Prev Cardiol"},{"key":"13687_CR37","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jacc.2019.08.014","volume":"74","author":"DL Dixon","year":"2019","unstructured":"Dixon DL, Sharma G, Sandesara PB, Yang E, Braun LT, Mensah GA, et al. Therapeutic inertia in cardiovascular disease prevention. J Am Coll Cardiol. 2019;74:1728\u201331. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.014.","journal-title":"J Am Coll Cardiol"},{"key":"13687_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12962-022-00377-w","volume":"20","author":"AD Scarffe","year":"2022","unstructured":"Scarffe AD, Licskai CJ, Ferrone M, Brand K, Thavorn K, Coyle D. Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting. Cost Eff Resource Allocation. 2022;20:39. https:\/\/doi.org\/10.1186\/s12962-022-00377-w.","journal-title":"Cost Eff Resource Allocation"},{"key":"13687_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41533-019-0119-9","volume":"29","author":"M Ferrone","year":"2019","unstructured":"Ferrone M, Masciantonio MG, Malus N, Stitt L, O\u2019Callahan T, Roberts Z, et al. The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Prim Care Respir Med. 2019;29:8. https:\/\/doi.org\/10.1038\/s41533-019-0119-9.","journal-title":"NPJ Prim Care Respir Med"},{"key":"13687_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3122\/jabfm.2020.04.190367","volume":"33","author":"EK Cottrell","year":"2020","unstructured":"Cottrell EK, O\u2019Malley JP, Dambrun K, Park B, Hendricks MA, Xu H, et al. The impact of social and clinical complexity on diabetes control measures. J Am Board Family Med. 2020;33:600\u201310. https:\/\/doi.org\/10.3122\/jabfm.2020.04.190367.","journal-title":"J Am Board Family Med"},{"key":"13687_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12916-021-01963-0","volume":"19","author":"R Philip","year":"2021","unstructured":"Philip R, Beaney T, Appelbaum N, Gonzalvez CR, Koldeweij C, Golestaneh AK, et al. Variation in hypertension clinical practice guidelines: a global comparison. BMC Med. 2021;19:117. https:\/\/doi.org\/10.1186\/s12916-021-01963-0.","journal-title":"BMC Med"},{"key":"13687_CR42","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. 2023. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"13687_CR43","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. 2024."},{"key":"13687_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321702","author":"A Norhammar","year":"2023","unstructured":"Norhammar A, Bodegard J, Vanderheyden M, Tangri N, Karasik A, Maggioni A, Pietro, et al. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure. Heart. 2023;:heartjnl-2022-321702. https:\/\/doi.org\/10.1136\/heartjnl-2022-321702.","journal-title":"Heart"},{"key":"13687_CR45","doi-asserted-by":"publisher","first-page":"100778","DOI":"10.1016\/j.lanepe.2023.100778","volume":"35","author":"F Kerwagen","year":"2023","unstructured":"Kerwagen F, Riemer U, Wachter R, von Haehling S, Abdin A, B\u00f6hm M, et al. Impact of the COVID-19 pandemic on implementation of novel guideline-directed medical therapies for heart failure in germany: a nationwide retrospective analysis. Lancet Reg Health - Europe. 2023;35:100778. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100778.","journal-title":"Lancet Reg Health - Europe"},{"key":"13687_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.3445","author":"LH Lund","year":"2024","unstructured":"Lund LH, Crespo-Leiro MG, Laroche C, Zaliaduonyte D, Saad AM, Fonseca C, et al. Heart failure in europe: Guideline\u2010directed medical therapy use and decision making in chronic and acute, pre\u2010existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction \u2013 the ESC EORP heart failure III registry. Eur J Heart Fail. 2024. https:\/\/doi.org\/10.1002\/ejhf.3445.","journal-title":"Eur J Heart Fail"},{"key":"13687_CR47","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, B\u00f6hm M, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2107038.","journal-title":"N Engl J Med"},{"key":"13687_CR48","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B, de Boer RA, DeMets D, Hernandez AF, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387:1089\u201398. https:\/\/doi.org\/10.1056\/NEJMoa2206286.","journal-title":"N Engl J Med"},{"key":"13687_CR49","doi-asserted-by":"publisher","first-page":"625","DOI":"10.18553\/jmcp.2021.20390","volume":"27","author":"SR Palli","year":"2021","unstructured":"Palli SR, Zhou S, Shaikh A, Willey VJ. Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy. J Manag Care Spec Pharm. 2021;27:625\u201337. https:\/\/doi.org\/10.18553\/jmcp.2021.20390.","journal-title":"J Manag Care Spec Pharm"},{"key":"13687_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1186\/s12913-021-06876-5","volume":"21","author":"N Gygli","year":"2021","unstructured":"Gygli N, Z\u00fa\u00f1iga F, Simon M. Regional variation of potentially avoidable hospitalisations in switzerland: an observational study. BMC Health Serv Res. 2021;21:849. https:\/\/doi.org\/10.1186\/s12913-021-06876-5.","journal-title":"BMC Health Serv Res"},{"key":"13687_CR51","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s42399-021-01005-z","volume":"3","author":"S Babapoor-Farrokhran","year":"2021","unstructured":"Babapoor-Farrokhran S, Alzubi J, Port Z, Sooknanan N, Ammari Z, Al-Sarie M, et al. Impact of COVID-19 on heart failure hospitalizations. SN Compr Clin Med. 2021;3:2088\u201392. https:\/\/doi.org\/10.1007\/s42399-021-01005-z.","journal-title":"SN Compr Clin Med"},{"key":"13687_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0735-1097(23)01107-5","volume":"81","author":"M Mignery","year":"2023","unstructured":"Mignery M, Lin P, Shore S. COVID-19 AND HEART FAILURE: THE PANDEMIC\u2019S EFFECT ON CHF HOSPITALIZATION, READMISSION, AND MORTALITY. J Am Coll Cardiol. 2023;81:663. https:\/\/doi.org\/10.1016\/S0735-1097(23)01107-5.","journal-title":"J Am Coll Cardiol"},{"key":"13687_CR53","doi-asserted-by":"publisher","first-page":"e0255659","DOI":"10.1371\/journal.pone.0255659","volume":"16","author":"JS Alqahtani","year":"2021","unstructured":"Alqahtani JS, Oyelade T, Aldhahir AM, Mendes RG, Alghamdi SM, Miravitlles M, et al. Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis. PLoS ONE. 2021;16:e0255659. https:\/\/doi.org\/10.1371\/journal.pone.0255659.","journal-title":"PLoS ONE"},{"key":"13687_CR54","doi-asserted-by":"publisher","unstructured":"Pappe E, Hammerich R, Saccomanno J, Sgarbossa T, Pohrt A, Schmidt B, et al. Impact of coronavirus disease 2019 on hospital Admissions, health Status, and behavioral changes of patients with COPD. Chronic Obstr Pulmonary Diseases: J COPD Foundation. 2023;211\u201323. https:\/\/doi.org\/10.15326\/jcopdf.2022.0383.","DOI":"10.15326\/jcopdf.2022.0383"},{"key":"13687_CR55","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.2147\/COPD.S415621","volume":"18","author":"D Puebla Neira","year":"2023","unstructured":"Puebla Neira D, Zaidan M, Nishi S, Duarte A, Lau C, Parthasarathy S, et al. Healthcare utilization in patients with chronic obstructive pulmonary disease discharged from coronavirus 2019 hospitalization. Int J Chron Obstruct Pulmon Dis. 2023;18:1827\u201335. https:\/\/doi.org\/10.2147\/COPD.S415621.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"13687_CR56","doi-asserted-by":"publisher","unstructured":"Ebinger JE, Driver M, Joung S, Tran T, Barajas D, Wu M, et al. Hypertension and excess risk for severe COVID-19 illness despite booster vaccination. Hypertension. 2022;79. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.19694.","DOI":"10.1161\/HYPERTENSIONAHA.122.19694"},{"key":"13687_CR57","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.healthpol.2020.07.008","volume":"124","author":"R Friebel","year":"2020","unstructured":"Friebel R, Juarez RM. Spill over effects of inpatient bed capacity on accident and emergency performance in England. Health Policy (New York). 2020;124:1182\u201391. https:\/\/doi.org\/10.1016\/j.healthpol.2020.07.008.","journal-title":"Health Policy (New York)"},{"key":"13687_CR58","doi-asserted-by":"publisher","first-page":"115399","DOI":"10.1016\/j.socscimed.2022.115399","volume":"313","author":"J Siverskog","year":"2022","unstructured":"Siverskog J, Henriksson M. The health cost of reducing hospital bed capacity. Soc Sci Med. 2022;313:115399. https:\/\/doi.org\/10.1016\/j.socscimed.2022.115399.","journal-title":"Soc Sci Med"},{"key":"13687_CR59","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/MLR.0000000000000342","volume":"53","author":"MO Falster","year":"2015","unstructured":"Falster MO, Jorm LR, Douglas KA, Blyth FM, Elliott RF, Leyland AH. Sociodemographic and health Characteristics, rather than primary care Supply, are major drivers of geographic variation in preventable hospitalizations in Australia. Med Care. 2015;53:436\u201345. https:\/\/doi.org\/10.1097\/MLR.0000000000000342.","journal-title":"Med Care"},{"key":"13687_CR60","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12913-020-05132-6","volume":"20","author":"G Mercier","year":"2020","unstructured":"Mercier G, Georgescu V, Plancque E, Duflos C, Le Pape A, Quantin C. The effect of primary care on potentially avoidable hospitalizations in france: a cross-sectional study. BMC Health Serv Res. 2020;20:268. https:\/\/doi.org\/10.1186\/s12913-020-05132-6.","journal-title":"BMC Health Serv Res"},{"key":"13687_CR61","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/eurheartj\/ehi251","volume":"26","author":"M Komajda","year":"2005","unstructured":"Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J. 2005;26:1653\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehi251.","journal-title":"Eur Heart J"},{"key":"13687_CR62","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ejhf.1459","volume":"21","author":"M Komajda","year":"2019","unstructured":"Komajda M, Sch\u00f6pe J, Wagenpfeil S, Tavazzi L, B\u00f6hm M, Ponikowski P, et al. Physicians\u2019 guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail. 2019;21:921\u20139. https:\/\/doi.org\/10.1002\/ejhf.1459.","journal-title":"Eur J Heart Fail"},{"key":"13687_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.annepidem.2023.12.003","volume":"96","author":"DL Weir","year":"2024","unstructured":"Weir DL, Bai YQ, Thavorn K, Guilcher S, Kanji S, Mulpuru S, et al. Non-adherence to COPD medications and its association with adverse events: A longitudinal population based cohort study of older adults. Ann Epidemiol. 2024;96:88\u201396. https:\/\/doi.org\/10.1016\/j.annepidem.2023.12.003.","journal-title":"Ann Epidemiol"},{"key":"13687_CR64","doi-asserted-by":"publisher","unstructured":"Gruebner O, Wei W, Ulyte A, von Wyl V, Dressel H, Br\u00fcngger B, et al. Small area variation of adherence to clinical recommendations: an example from Switzerland. Health Serv Res Manag Epidemiol. 2022;9. https:\/\/doi.org\/10.1177\/23333928221097741.","DOI":"10.1177\/23333928221097741"},{"key":"13687_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6947-8-38","volume":"8","author":"AL Francke","year":"2008","unstructured":"Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review. BMC Med Inf Decis Mak. 2008;8:38. https:\/\/doi.org\/10.1186\/1472-6947-8-38.","journal-title":"BMC Med Inf Decis Mak"},{"key":"13687_CR66","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.healthpol.2018.03.006","volume":"122","author":"S Schussel\u00e9 Filliettaz","year":"2018","unstructured":"Schussel\u00e9 Filliettaz S, Berchtold P, Kohler D, Peytremann-Bridevaux I. Integrated care in switzerland: results from the first nationwide survey. Health Policy (New York). 2018;122:568\u201376. https:\/\/doi.org\/10.1016\/j.healthpol.2018.03.006.","journal-title":"Health Policy (New York)"},{"key":"13687_CR67","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41746-025-01871-0","volume":"8","author":"L O\u2019Connor","year":"2025","unstructured":"O\u2019Connor L, Wang B, Ye Z, Behar S, Tarrant S, Stamegna P, et al. Evaluation of an integrated digital and mobile intervention to improve outcomes for patients with moderate to severe COPD. NPJ Digit Med. 2025;8:451. https:\/\/doi.org\/10.1038\/s41746-025-01871-0.","journal-title":"NPJ Digit Med"},{"key":"13687_CR68","doi-asserted-by":"publisher","first-page":"1701567","DOI":"10.1183\/13993003.01567-2017","volume":"51","author":"L Rose","year":"2018","unstructured":"Rose L, Istanboulian L, Carriere L, Thomas A, Lee H-B, Rezaie S, et al. Program of integrated care for patients with chronic obstructive pulmonary disease and multiple comorbidities (PIC COPD +): a randomised controlled trial. Eur Respir J. 2018;51:1701567. https:\/\/doi.org\/10.1183\/13993003.01567-2017.","journal-title":"Eur Respir J"},{"key":"13687_CR69","doi-asserted-by":"publisher","unstructured":"Sch\u00fctz Leuthold M, El Hakmaoui F, Scuderi R, Senn N, Cohidon C. Patients\u2019 experience of integrated nursing care in general practices in switzerland: a mixed-methods study. Fam Pract. 2025;42. https:\/\/doi.org\/10.1093\/fampra\/cmaf011.","DOI":"10.1093\/fampra\/cmaf011"},{"key":"13687_CR70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10198-022-01486-2","volume":"24","author":"M H\u00f6glinger","year":"2023","unstructured":"H\u00f6glinger M, Wirth B, Carlander M, Caviglia C, Frei C, Rhomberg B, et al. Impact of a diabetes disease management program on guideline-adherent care, hospitalization risk and health care costs: a propensity score matching study using real-world data. Eur J Health Econ. 2023;24:469\u201378. https:\/\/doi.org\/10.1007\/s10198-022-01486-2.","journal-title":"Eur J Health Econ"},{"key":"13687_CR71","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.pec.2021.06.018","volume":"105","author":"A Strassmann","year":"2022","unstructured":"Strassmann A, Guler M, Steurer-Stey C, Lana KD, Carron T, Braun J, et al. Nationwide implementation of the self-management program living well with COPD: process and effectiveness evaluation using a mixed-methods approach. Patient Educ Couns. 2022;105:670\u20138. https:\/\/doi.org\/10.1016\/j.pec.2021.06.018.","journal-title":"Patient Educ Couns"},{"key":"13687_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41533-024-00361-2","volume":"34","author":"AY Bischof","year":"2024","unstructured":"Bischof AY, Cordier J, Vogel J, Geissler A. Medication adherence halves COPD patients\u2019 hospitalization risk \u2013 evidence from Swiss health insurance data. NPJ Prim Care Respir Med. 2024;34:1. https:\/\/doi.org\/10.1038\/s41533-024-00361-2.","journal-title":"NPJ Prim Care Respir Med"},{"key":"13687_CR73","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.3390\/ijerph20196854","volume":"20","author":"D Erku","year":"2023","unstructured":"Erku D, Khatri R, Endalamaw A, Wolka E, Nigatu F, Zewdie A, et al. Digital health interventions to improve access to and quality of primary health care services: A scoping review. Int J Environ Res Public Health. 2023;20:6854. https:\/\/doi.org\/10.3390\/ijerph20196854.","journal-title":"Int J Environ Res Public Health"},{"key":"13687_CR74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s44247-024-00103-x","volume":"2","author":"V Mishra","year":"2024","unstructured":"Mishra V, Stuckler D, McNamara CL. Digital interventions to reduce hospitalization and hospital readmission for chronic obstructive pulmonary disease (COPD) patient: systematic review. BMC Digit Health. 2024;2:46. https:\/\/doi.org\/10.1186\/s44247-024-00103-x.","journal-title":"BMC Digit Health"},{"key":"13687_CR75","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ehjdh\/ztae064","volume":"5","author":"MJ Schuuring","year":"2024","unstructured":"Schuuring MJ, Treskes RW, Castiello T, Jensen MT, Casado-Arroyo R, Neubeck L, et al. Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC working group on e-Cardiology, the heart failure association of the European society of Cardiology, the association of cardiovascular nursing & allied professions of the European society of Cardiology, the ESC digital health Committee, the ESC Council of Cardio-Oncology, and the ESC patient forum. Eur Heart J - Digit Health. 2024;5:670\u201382. https:\/\/doi.org\/10.1093\/ehjdh\/ztae064.","journal-title":"Eur Heart J - Digit Health"},{"key":"13687_CR76","doi-asserted-by":"publisher","first-page":"e091046","DOI":"10.1136\/bmjopen-2024-091046","volume":"15","author":"AL Ciminelli","year":"2025","unstructured":"Ciminelli AL, Polachini A, Gon\u00e7alves B, Sandhu AT, Rezende LC, Lino RZS, Bramucci V, et al. Digital health intervention to optimise heart failure management after hospital discharge in Brazil (OPT-HF): a randomised clinical trial protocol. BMJ Open. 2025;15:e091046. https:\/\/doi.org\/10.1136\/bmjopen-2024-091046.","journal-title":"BMJ Open"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13687-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:03:16Z","timestamp":1764028996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13687-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13687"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13687-5","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.heliyon.2024.e40466","asserted-by":"subject"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was exempt from a formal review and approval by the Ethics Committee of the University of St. Gallen. Ethical approval as well as consent to participate were not required because all case-level data and employment data of primary care physicians were anonymized, and population data were aggregated by canton, sex, and age making individual identification impossible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.CJ. declares that he is employed by the AstraZeneca AG. J.V. declares that he co-conducted a scientific workshop on clinical practice guideline adherence funded by the AstraZeneca AG.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1514"}}